Licoisoflavone B inhibits the activity of insulin receptors by binding to the hydroxyl group of the receptor. It also inhibits protein transport in cancer cells and has been shown to have an inhibitory effect on chemical structures that are involved in tumor formation. This product can be used for anticancer activity screening.
Molecular Weight
352.34
Molecular Formula
C20H16O6
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
Licoisoflavone B can be used for anticancer activity screening.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
